☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Death
AstraZeneca's Farxiga (dapagliflozin) Receives the US FDA's Priority Review Voucher for the Reduction of CV Risks and Death in Pat...
January 6, 2020
Boston Scientific Reports Results of Emblem S-ICD System in UNTOUCHED Study to Prevent Sudden Cardiac Death
May 13, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.